Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Breast Neoplasms 2 Oligodendroglioma 1 Neurocytoma 1 Neoplasms, Neuroepithelial 1 NF1 1 Multiple Myeloma 1 Melanoma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Glioma 1 Ganglioneuroma 1 Ganglioglioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Astrocytoma 1 Advanced Solid Tumor 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × NF1 × mirdametinib × Clear all

NCT06159166 2026-04-13

Mirda

Johns Hopkins University

Phase 1/2 Recruiting

CNSDermatologic

NF1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡